Drugs / Carperitide
Carperitide
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT00259038 | Jan 2004 → Feb 2006 | cardiomyopathy, left ventricular failure | Daiichi Sankyo | Completed | No outcome recorded |
| Phase 2 | NCT00030121 | Dec 1999 → ? | acute respiratory distress syndrome | Suntory Pharmaceutical | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00613964 Comparator | May 2009 → May 2013 | heart failure, kidney failure | Nara Medical University | Terminated | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Carperitide | “A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Evaluation of the Safety and Efficacy of Carperitide Infusion in Patients With ARDS” NCT00030121 ↗ |
| Known as | alpha-human atrial natriuretic peptide | “carperitide(alpha-human atrial natriuretic peptide, 0.025-0.05μg/kg/min)” NCT00613964 ↗ |
| Known as | Atrial natriuretic peptide | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104386 ↗ |
| Known as | Atrial natriuretic peptide carperitide | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104386 ↗ |
| Known as | Carperitida | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104386 ↗ |
| Known as | Hanp | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104386 ↗ |
| Known as | SUN 4936 | ChEMBL registry synonym — accepted as the source's own label CHEMBL2104386 ↗ |
| Modality | Peptide | “recombinant human atrial natriuretic polypeptide” NCT00030121 ↗ |
| Route | Intravenous | “intravenous infusion of carperitide” NCT00259038 ↗ |